Accumulating evidence points to an evolving process of brain injury after intrapartum hypoxia-ischemia that initiates in utero and extends into a recovery period. The processes leading to cell death include necrosis or apoptosis, and result from the combined effects of cellular energy failure, acidosis, glutamate release, intracellular Ca 2 þ accumulation, generation of free radicals that serve to disrupt essential components of the cell. Many factors including the duration or severity of the insult influence the progression of cellular injury after hypoxia-ischemia. A secondary cerebral energy failure occurs from 6 to 48 h after the primary event and involves mitochondrial dysfunction secondary to extended reactions from primary insults (e.g., calcium influx, excitatory neurotoxicity and oxygen free radicals) as well as the release of circulatory and endogenous inflammatory cells/mediators that also contribute to ongoing brain injury. Strategies aimed at neuroprotection need to be comprehensive targeting the pathways leading to eventual mitochondrial injury.
Introduction
Impaired cerebral blood flow (CBF) is the predominant pathogenetic mechanism underlying most of the neuropathology attributed to intrapartum hypoxia-ischemia. 1 This disruption in CBF is most likely to occur as a consequence of interruption in placental blood flow and gas exchange that may be acute and/or intermittent. The fetus adapts in multiple ways including both circulatory and noncirculatory responses to preserve cerebral perfusion and thus oxygen delivery. However, when the disruption is severe and/or the adaptive mechanisms fail, neuronal cell death ensues. Brain injury may occur in two phases, during the acute insult and during a recovery period following circulatory restoration termed reperfusion injury. This article will deal with interruption of placental blood flow, the fetal adaptive responses to this state, and the mechanisms contributing to acute and delayed perinatal hypoxic-ischemic brain injury.
Defining asphyxia
The definition of birth asphyxia is imprecise. The process occurs during the first and second stages of labor and a fairly consistent description is that of a condition of impaired gas exchange which if persistent leads to hypoxemia and hypercapnia. The process is identified by fetal acidosis (as measured in umbilical arterial blood), which reflects the degree of anaerobic metabolism generated during periods of hypoxia or increased oxygen demand. 2 The umbilical arterial pH that best defines 'asphyxia' remains unclear. Initially, asphyxia was defined as a cord umbilical arterial pH less than 7.20 . With this definition, the incidence of 'asphyxia' ranged from 5 to 20%. 3 If a pH less than 7.10 was used, the incidence ranges from 2 to 8%. 4 Accumulating evidence suggests that an umbilical arterial pH less than7.00 reflects degrees of acidosis often referred to as pathologic or severe fetal acidemia, where the risk of adverse neurologic sequelae is increased. 5, 6 A cord pH less than7.0 complicates approximately 0.3% of all deliveries. 5, 7 Even with this degree of acidosis, the likelihood of brain injury is low. Thus the majority of infants, that is, greater than 60%, exhibit no difficulties in the delivery room, are triaged to the regular newborn nursery, and exhibit an uncomplicated neonatal course in almost all cases. 7 Even when infants with severe fetal acidemia are admitted to intensive care (usually because of respiratory difficulties) about 80 to 90% exhibit a benign neurologic course [8] [9] [10] and it is only a small percentage that progress to moderate to severe encephalopathy, that is approximately 10% of all infants delivered in the presence of severe fetal acidemia. 7, 10 This resilience of the brain is in part based on the ability of the fetus to adapt to the interruption of placental blood flow to preserve cerebral perfusion and oxygen delivery.
Cerebral responses to interruption of placental blood flow Biochemical The cerebral circulation is exquisitely sensitive to changes in PaO 2 and PaCO 2 . Thus, interruption of placental blood flow with hypoxia and hypercarbia both independently increase CBF. [11] [12] [13] In addition, the vascular responses to both partial pressure of carbondioxide (PaCO 2 ) and partial pressure of oxygen (PaO 2 ) vary widely amongst brain regions. For example, cerebral white matter as compared to brainstem and cortical structures has limited vasodilatory responses to both PaCO 2 and hypoxia.
Autoregulation
In the usual state CBF remains constant over a wide range of changes in systemic mean arterial blood pressure, a term referred to as autoregulation. 15 The fetal curve differs from the adult curve in two ways. First, the curve is narrower, particularly at the upper limit, in the less mature animal, and second the normal mean arterial blood pressure in the less mature animal is only marginally above the lower limit of the curve. 16, 17 Autoregulation may be disrupted with hypoxia, hypo/hypercarbia or acidosis. 14, [18] [19] [20] [21] Under such conditions, the cerebral circulation becomes pressure passive and directly reflects systemic blood pressure changes. The importance of impaired CBF autoregulation, even after modest asphyxia in the genesis of ischemic cerebral injury is supported by animal and experimental studies. 14, 22 The implications are enormous, namely a decrease in blood pressure will result in a decrease in CBF, thus markedly increasing the vulnerability for neuronal injury, particularly within the border zone regions of the brain such as parasagittal cortex or periventricular white matter. 14 
Fetal adaptation to interruption of placental blood flow

Circulatory responses
The important circulatory manifestations of interruption of placental blood flow have been well categorized in experimental studies. These include: (1) a redistribution of cardiac output to preserve blood flow to the more vital organs (i.e., brain, myocardium, adrenal gland) with reduced flow to less vital organs (i.e., kidney, intestine, muscle); (2) loss of cerebral vascular autoregulation resulting in a pressure passive circulation as described above; and (3) eventual diminution in cardiac output with resultant hypotension, and ultimately a critical decrease in cerebral perfusion and oxygen delivery (Figure 1) . [23] [24] [25] [26] [27] [28] The mechanisms involved in the redistribution of blood flow include peripheral vasoconstriction, which is triggered by a carotid chemoreflex, endocrine factors and then maintained or subsequently modified by endocrine and local components. 29, 30 In the experimental model, with initial arterial hypoxemia, fetal vascular resistance can decrease by at least 50% to maintain CBF with a minimal decrease in oxygen delivery. [31] [32] [33] Critical to this state is a normal or elevated mean arterial blood pressure. However, with persistent hypoxemia, and eventual hypotension, cerebral vascular resistance cannot decrease further, resulting in a marked reduction in CBF. 34 The critical ischemic threshold for neuronal necrosis in developing brain remains unclear. Clearly, postnatal observations indicate that this is a very complex issue. In adults, CBF thresholds have been identified; below a critical threshold functional disturbances (electroencephalographic slowing) occur, 35 and below an even lower CBF threshold ion pump failure occurs. 36, 37 Yet, values in both preterm and term infants below the threshold associated with pump failure in adults have been associated with subsequent normal neurologic development. 38 Noncirculatory factors contributing to neuronal preservation Additional factors considered potentially important in preserving neuronal integrity with asphyxia include biologic alterations that are maturation dependent. Some examples include: (1) decreasing rate of brain metabolism during early development that results in a slower depletion of high-energy compounds during hypoxiaischemia in the fetus as compared with the term infant or adult; 39, 40 (2) the use of alternate energy substrate, the neonatal brain having the capacity to use lactate and ketone bodies for energy production; 41, 42 (3) the relative resistance of the fetal and neonatal myocardium to hypoxia ischemia; 43, 44 and (4) the potential protective role of fetal hemoglobin, that is, it has been calculated that if the PO 2 were to decrease to below a value of approximately 3 torr, and if the venous PO 2 were to decrease to 10 torr (a value that may be found in the cerebral venous blood with asphyxia), the infant would have more oxygen available for brain uptake with a fetal rather than with an adult dissociation curve. 45 Recent data suggest a potential important role for ischemic preconditioning. 46 Perhaps as a consequence of some or all of the above-mentioned factors, even when interruption of placental blood flow, that is asphyxia is prolonged or severe, most newborn infants recover with minimal or no neurologic sequelae.
Mechanisms of neuronal cell death following hypoxia-ischemia
The mechanism of neuronal cell death in animals and humans after hypoxia-ischemia includes neuronal necrosis and apoptosis. 47 
Figure 1
Schematic depicting the circulatory responses to interruption of placental blood flow. Note the increased blood flow to brain, heart and adrenal glands at the expense of blood flow to the less vital organs.
Necrosis is a passive process of cell swelling, with disruption of cytoplasmic organelles, loss of membrane integrity, eventual lysis of neuronal cells and activation of an inflammatory process. In contrast, apoptosis is an active process distinguished from necrosis by the presence of cell shrinkage, nuclear pyknosis, chromatin condensation and genomic fragmentation, events that occur in the absence of an inflammatory response. 48 Two parallel pathways lead to chromatin processing during apoptosis. One an intrinsic pathway that involves activation of caspase-3, cleavage of inhibitor of caspase-activated DNAse with subsequent activation of caspaseactivated DNAse which in turn produces oligonucleosomal DNA fragmentation and advanced chromatin condensation. 49 The second pathway involves apoptosis-inducible factor (AIF) that is caspase independent and results in DNA fragmentation and chromatin condensation. 50 These two processes of neuronal death can be found after hypoxia-ischemia in both animals and humans. 14, 51 Several factors appear to be important in determining the mode of death. The first relates to the intensity of the initial insult with severe injury resulting in necrosis and milder insults resulting in apoptosis. 48 The second relates to the impact of age on cell death mechanisms. 52 Thus, there is a developmental downregulation of caspase-3 as well as other elements involved in caspase-3 activation, that is Bcl-2-associated X protein that occurs in tandem with a reduction with physiologic programmed cell death seen in the mature brain. Cytochrome c a critical component of the respiratory chain that generates adenosine triphosphate (ATP) in the inner mitochondrial membrane increases during brain development. 52, 53 In addition, there is a relative downregulation of AIF with maturation. 52 Calpains, which are cysteine proteases located within the cytoplasm, are activated by intracellular calcium elevation and have been implicated in excitotoxic neuronal injury. 54 Again, there is a maturational difference with caspain activity peaking 3 hour after hypoxia-ischemia in immature brain whereas in the mature brain it peaks later, that is at 72 hour and beyond. 52 Clearly, because the mechanisms of cell death that is necrosis versus apoptosis differ, strategies to minimize brain damage in an affected infant after hypoxia-ischemia likely will have to include interventions that target both processes.
Importance of the mitochondria to the processes of cell death Mitochondria appear to play a central role in determining the fate of cells subjected to hypoxia-ischemia. 55 Mitochondria are major buffers of intracellular calcium ions and can become overloaded by cytoplasmic Ca 2 þ flooding secondary to opening of N-methyl-D-aspartate (NMDA) and voltage-sensitive Ca 2 þ channels. Diminished mitochondrial function can lead to decreased energy production to maintain membrane ion gradients, potentially perpetuating a vicious cycle of membrane depolarization and NMDA receptor channel opening. 56 In addition, mitochondria handle multiple oxidation reactions that can yield highly toxic oxygen free radicals under conditions of oxidative stress (Figure 2 ). Mitochondria are key regulators in the process of cell death via release of the numerous proapoptotic proteins such as cytochrome c, caspase-2 and -9, and AIF from the intermembrane space. [57] [58] [59] These key elements of apoptosis, that is caspase-3, caspase-12 and BAX, are upregulated in the immature brain. 52, 59 Caspases are cysteine proteases that orchestrate in a proteolytic cascade, targeting key homeostatic and structural proteins, leading to DNA fragmentation and cell death. The release of caspase-3 has recently been categorized in a series of experiments. Thus, during the primary phase of mitochondrial dysfunction there is limited activation of caspase-3 whereas secondary damage is associated with neuronal loss and a striking elevation in caspase-3. 60 The pathways leading to caspase activation have not been fully elucidated but there are data suggesting that proapoptotic proteins (cytochrome c and apoptosis-inducing factor) are released from mitochondria. Cytochrome c interacts with APAF-1 (apoptosis protease-activating factor 1) and caspase-9, leading to further activation of downstream caspases. 61 Activation of caspase-3 is much more pronounced in the immature than in the adult brain in response to various hypoxic-ischemic insults 62, 63 with activity increasing progressively between 1 and 24 hour of reperfusion. 63 Caspase inhibition reduces brain injury after neonatal HI, supporting a critical role in HI injury and a potential avenue for neuroprotection. 63 AIF, which acts independently of caspases, translocates to the nucleus and induces chromatin condensation and DNA fragmentation. 50 ,62 AIF levels do not change during development, which is in contrast to the increase in the apoptosisrelated intermembrane mitochondrial proteins cytochrome c and caspase. AIF is released earlier from mitochondria shortly after hypoxia-ischemia and precedes that of cytochrome c. 
Mechanisms contributing to neuronal necrosis/apoptosis following hypoxia-ischemia
Brain injury likely occurs in two phases in most cases, that is during the acute insult and secondarily during the recovery period following circulatory restoration, termed reperfusion injury (Figure 3 ).
Acute injury
At the cellular level, the reduction in CBF and oxygen delivery to a critical level initiates a cascade of deleterious biochemical events. Thus, oxygen depletion results in a switch to anaerobic metabolism an energy-inefficient state with a rapid depletion of high-energy phosphate reserves, including ATP, accumulation of lactic acid; and an inability to maintain cellular functions. 64 These changes result in disruption of transcellular ion pumping, with the subsequent intracellular accumulation of sodium, calcium, and water. As a result of the membrane depolarization there is a release of excitatory neurotransmitters, specifically glutamate, from axon terminals. Glutamate then activates specific cell surface receptors, resulting in a further influx of Na þ and Ca 2 þ into postsynaptic neurons. Within the cytoplasm, free fatty acids accumulate secondary to increased membrane phospholipid turnover. The fatty acids undergo peroxidation by oxygen free radicals that arise from reductive processes within mitochondria and as well as from by-products in the synthesis of prostaglandins, xanthine and uric acid (Figure 3) . Ca 2 þ ions accumulate within the cytoplasm as a consequence of increased cellular influx as well as decreased efflux across the plasma membrane associated with release from mitochondria and endoplasmic reticulum. In selected neurons, the intracellular calcium induces the production of nitric oxide (NO), a free radical that diffuses to adjacent cells susceptible to NO toxicity. The combined effects of cellular energy failure, acidosis, glutamate release, intracellular Ca 2 þ accumulation, lipid peroxidation, and NO neurotoxicity disrupt essential components of the cell, resulting in death. 1, 14, 56, 65, 66 Many factors, including the duration or severity of the insult, influence the progression of cellular injury after hypoxia-ischemia.
Delayed (secondary) brain damage
Following resuscitation, which occurs in the delivery room, cerebral perfusion and oxygenation is restored. During this recovery phase, the concentrations of phosphorus metabolites and the intracellular pH return to baseline. However, a process of cerebral energy failure recurs from 6 to 48 h later in a second phase of injury. This phase, is characterized by a decrease in the ratio of phosphocreatine/inorganic phosphate, an unchanged intracellular pH, and stable cardio respiratory status, contributes to further brain injury. 64, 67 In the human infant, the severity of the second energy failure is correlated with adverse neurodevelopmental outcome at 1 and 4 years. 68 The mechanisms of secondary energy failure may involve mitochondrial dysfunction secondary to extended reactions from primary insults (e.g., calcium influx, excitatory neurotoxicity, oxygen free radicals or NO formation). Evidence suggests that circulatory and endogenous inflammatory cells/mediators also contribute to ongoing brain injury. 66, 68, 69 Specific mechanisms of injury Accumulation of cytosolic calcium Calcium an intracellular secondary messenger is necessary for numerous cellular reactions. Under physiologic conditions, cytosolic Ca 2 þ concentration is strictly regulated at a very low intracellular concentration. During hypoxia-ischemia, there is an increase in Ca 2 þ influx into neuronal cells caused in part by stimulation of the N-methyl d-aspartate receptors of the agonistoperated Ca 2 þ channel by glutamate. In an opposite direction, Ca 2 þ efflux across the plasma membrane is interrupted by the energy failure. In addition, Ca 2 þ is also released into cytoplasm from the mitochondria by the Na þ H þ -dependent antiport system and from the endoplasmic reticulum by inositol triphosphate derived from the plasma membrane. This results in increased intracellular Ca 2 þ , which interferes with many enzymatic reactions, including activation of lipases, proteases, endonucleases, and phospholipases, and the formation of oxygen free radicals as by-products of prostaglandin synthesis. Overall, the accumulation of cytosolic Ca 2 þ after hypoxia-ischemia has major detrimental effects on neuronal cells leading to irreversible brain damage. 14, 56 Excitatory neurotransmitter release Glutamic acid is a major excitatory amino acid within the brain. The action of glutamate is mediated by a number of receptor subtypes, with the NMDA receptor predominating in the developing brain, and is increased in areas of active development (e.g., striatum or hippocampus). Within the NMDA receptor site, there are regions of agonist activity (glutamate, glycine) as well as regions of antagonist activity (Mg 2 þ or phencyclidine (PCP)). 14, 56, 65 Glutamate metabolism has been shown to be tightly coupled to glucose metabolism within neurons. During hypoxia-ischemia, glutamate accumulates within the synaptic cleft, secondary to increased release from axon terminals as well as impaired reuptake at presynaptic nerve endings. The excessive glutamate acting on the receptor sites facilitates the intracellular entry of Ca 2 þ via the NMDA receptor-mediated channel and promotes the biochemical cascade mentioned above, leading to neuronal death. 14, 56, 66 Formation of free radicals Oxygen free radicals (O 2 À , H 2 O 2 , OH À ) are produced within the cytoplasm and mitochondria under physiologic conditions. The free radicals are destroyed rapidly by endogenous antioxidants (e.g., superoxide dismutase and catalase) and scavengers (e.g., a-tocopherol, ascorbic acid and glutathione).
14,66,69 During and following hypoxia-ischemia, the generation of oxygen free radicals is increased in excess of the protective capability of the cell. Two important sources of oxygen free radicals are the by-products of xanthine (derived from the breakdown of ATP) and prostaglandin synthesis (derived from the breakdown of free fatty acids) (Figure 2 ). Oxygen free radicals contribute to tissue injury by attacking the polyunsaturated fatty acid component of the cellular membrane, resulting in membrane fragmentation and cell death. 14, 56, 66 The developing brain appears to be extremely vulnerable to oxidative damage in part because of the high concentrations of unsaturated fatty acids, a high rate of oxygen consumption and relatively low concentrations of antioxidants. 14 Another source of free radical formation is NO, which is formed during the conversion of L-arginine into L-citrulline by NO synthase (NOS). NOS is strongly activated during hypoxia-ischemia and with reperfusion, and a large amount of NO is produced for extended periods. When combined with superoxide, NO generates a potent radical, peroxynitrite, which activates lipid peroxidation. In addition, NO enhances glutamate release. 14, 66, 69 An additional pathway of free radical induced injury is via the release of iron. Physiologically, iron is maintained in a nontoxic ferric state and is bound to proteins (ferritin, transferrin). During hypoxia-ischemia, free ferric iron is released from these proteins and reacts with peroxides to generate potent hydroxyl radicals. In addition, free ferric iron is reduced to a ferrous form, which further contributes to free radical injury. 14, 69 Inflammatory mediators Inflammatory mediators appear to play a critical role in the pathogenesis of hypoxic-ischemic brain injury. 70 Expression of interleukin (IL)-1-b and tumor necrosis factor (TNF)-a messenger RNA (mRNA) has been demonstrated within 1 to 4 h after hypoxia-ischemia, 71 along with the induction of a and b chemokines followed by neutrophil invasion of the area of infarction. 72 Furthermore, a low dose of bacterial endotoxin administered 4 h before hypoxia-ischemia in rats induces cerebral infarction in response to short periods of hypoxia-ischemia that usually cause little or no injury. This endotoxin-induced sensitization of the immature brain occurs independent of CBF changes and/or hyperthermia and is associated with an altered expression of CD14 mRNA. 73 Inflammatory cytokines may have a direct toxic effect via increased production of inducible NOS, cyclooxygenase, and free radical release, or indirectly via induction of glial cells to produce neurotoxic factors such as excitatory amino acids. The important role of cytokines in perpetuating excitotoxic injury is suggested from experimental observations in which administration of interleukin-1 endogenous receptor antagonists and neutralizing antibody are associated with a reduction in excitotoxic and ischemic injury in mice. 74, 75 However, cytokines that potentiate brain damage after ischemia also appear to play a beneficial neurotrophic effect. TNF knockout mice were shown to have increased neuronal cell degeneration after ischemia and excitotoxic injury, suggesting a critical role for endogenous TNF in regulating the cellular responses to brain injury. 76 In addition, administration of exogenous interleukin-6 following ischemia produced by middle artery occlusion also results in marked neuroprotection. 77 Thus, inflammatory cytokines appear to exert both beneficial and deleterious effects after ischemia. This dual effect will likely complicate the task of developing targeted interventions against the inflammatory response.
Summary
The processes leading to neuronal cell death are initiated during an acute event with a loss of high-energy phosphate compounds, intracellular acidosis followed by excessive extracellular glutamate accumulation within the extracellular milieu, intracellular accumulation of calcium, free radical generation as well as activation of inflammatory mediators that may extend well beyond the initial process.
Translating basic science into clinical practice Under most circumstances infants at highest risk for evolving to brain injury secondary to intrapartum hypoxia-ischemia are initially identified in the immediate neonatal period starting as early as in the delivery room and extending through the first six postnatal hours. 78 Given the complex pathways of pathogenesis, it is unreasonable to expect that one intervention will suffice for all infants. Rather, any intervention is likely to vary depending on factors such as the severity or duration of the process. Currently, induced modest hypothermia likely reflecting its multiple actions on the pathways mentioned above, offers the greatest promise, particularly in infants who present with moderate encephalopathy and without early seizures. 79, 80 However, for infants with severe encephalopathy and/or early seizures, this effect is less favorable. 79, 80 The latter observations likely reflect a pathway of injury that is already destined toward necrosis rather than apoptosis. Thus, strategies for such infants may still include hypothermia (to 'dampen' down the multiple deleterious pathways and thus extend the 'therapeutic window' plus other targeted interventions. Examples may include the prophylactic and/or aggressive treatment of seizures, 81, 82 blocking the effects of glutamate, 83 combating inflammatory responses, 84, 85 inhibiting apoptosis 68, 86 and the administration of growth factors. 87 
